BioSpace News Archive

Campaign Designed to Drive Discussion About Treatment Innovations; Activities to Include National Media Tour and Town Hall Meetings Throughout the U.S.

Novartis announced that the U.S. Food and Drug Administration (FDA) accepted the company’s Biologics License Application (BLA) for brolucizumab (RTH258) for the treatment of wet age-related macular degeneration (AMD), also known as neovascular AMD, or nAMD.

Siddhartha Mukherjee has delighted, informed, and touched a wide audience through his books and essays, for which he will be awarded the 2019 Lewis Thomas Prize for Writing about Science.

Three-year collaboration to catalyze novel science and technology solutions to expand healthy longevity and eliminate diseases around the world

Pulse Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 28,000 shares of Pulse Biosciences common stock to three new non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on April 15, 2019.

A Kentucky woman filed the first lawsuit in the nation in the Salmonella outbreak linked to pre-cut melons produced by Caito Foods.

The Company Joins the Bleeding Disorder’s Community to Celebrate

Oxford Treatment Center is hosting a free community event on the topic of underage drinking and its effects on teens and young adults.

$2.3 million raised to support genomic medicine program at Children’s

On behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, the Honourable Jim Carr, Minister of International Trade Diversification, and the Honourable Cameron Friesen, Minister of Health, Seniors and Active Living for the Province of Manitoba will announce a bilateral agreement.